Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NK InSight

Financiado

Exploring Natural Immunity in Retinal Neovascular Disease

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the world. The number of people with AMD has reached 196 million, with ~1 in 10 people over 55 years already showing early signs of the condi... ver más

30/06/2028

TRINITY COLLEGE DU...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-06-05

ERC-2022-COG: ERC CONSOLIDATOR GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

TRINITY COLLEGE DUBLIN

2.00M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-117875GB-I00 MIRNAS COMO MODULADORES DE LA NEOVASCULARIZACION EN LA RETIN... 79K€ Cerrado

SAF2012-35562 NEUROPROTECCION EN LA RETINOPATIA DIABETICA: UNA NUEVA ESTRA... 187K€ Cerrado

SAF2013-41059-R ESTRATEGIAS NEUROPROTECTORAS PARA LA RETINOSIS PIGMENTARIA B... 357K€ Cerrado

NeoVasculoStop NATURAL INTRAOCULAR PHOTOACTIVATION OF COMPOUNDS TO FIGHT RE... 3M€ Cerrado

CNS2023-144390 Fisiopatología de órganos y sistemas 200K€ Cerrado

SAF2014-62114-EXP RUPTURA DE LA BARRERA HEMATORRETINIANA: CAUSA O CONSECUENCIA... 73K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2023-06-05
Fecha Fin: 2028-06-30

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the world. The number of people with AMD has reached 196 million, with ~1 in 10 people over 55 years already showing early signs of the condition. 70% of those who progress to late-stage disease will develop neovascular (nv)AMD due to uncontrolled growth of blood vessels behind the retina. In fact, aberrant growth of retinal or choroidal vasculature is a hallmark of diabetic retinopathy and nvAMD. Collectively, these are the most common causes of central vision loss globally. Identification of new biological processes that regulate neovascularization are urgently needed to open new therapeutic options for patients. This is a challenge; but with recent longitudinal studies showing unequivocally that current gold-standard care has a therapeutic ceiling, it presents a critical unmet clinical need. I have recently discovered that natural killer cells (NKs) are found in neovascular lesions in human AMD and our mouse model data suggests that these innate lymphoid cells (ILCs) play a role in inhibiting pathology. Using scRNAsequencing I discovered a defined subset of NKs in neovascular lesions in a model of resolving nvAMD. I now hypothesize that, in contrast to expectations, these ILCs play a critical role in remodelling neovascular lesions, limiting pathology as opposed to exacerbating it. NK cells are completely unstudied in the retina. Here, I propose that manipulating NK cells may represent a novel therapeutic strategy for the prevention and treatment of neovascular eye disease. Objectives: 1) Examine NK cell function in models of retinal neovascular disease 2) Profile NK cells in AMD pathology in a human study 3) Develop microfluidic neovascular retina-on-a-chip model to examine NK cell mechanism-of-action 4) Determine if NK cell therapy can ameliorate neovascular eye disease Goal: To harness the power of NK cell activity to treat neovascular eye diseases

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores